economy
XtalPi IPO: Risks, Valuation, and Future of AI Drug Discovery
Is the XtalPi IPO a breakthrough for AI drug discovery or a risky bet on unproven technology? We analyze the valuation, financials, and key challenges facing this high-profile biotech listing.